IL-33/IL-31 axis: A new pathological mechanisms for EGFR tyrosine kinase inhibitors-associated skin toxicity

IL-33: A Novel Danger Signal System in Atopic Dermatitis

(2012) Ferda Cevikbas et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Activation of Eosinophils Interacting with Dermal Fibroblasts by Pruritogenic Cytokine IL-31 and Alarmin IL-33: Implications in Atopic Dermatitis

(2012) Chun-Kwok Wong et al.   PLoS One

Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors

(2012) L. Peuvrel et al.   SUPPORTIVE CARE IN CANCER

Ultraviolet B radiation and reactive oxygen species modulate interleukin-31 expression in T lymphocytes, monocytes and dendritic cells

(2011) C. Cornelissen et al.   BRITISH JOURNAL OF DERMATOLOGY

Signaling by IL-31 and functional consequences

(2011) Christian Cornelissen et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

Keratinocytes synthesize and activate cortisol

(2011) Nicola Cirillo et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

The inflammatory response of keratinocytes and its modulation by vitamin D: The role of MAPK signaling pathways

(2011) Mor Miodovnik et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Mast Cells as Sensors of Cell Injury through IL-33 Recognition

(2011) M. Enoksson et al.   JOURNAL OF IMMUNOLOGY

Histopathologic and Immunohistochemical Characterization of Rash to Human Epidermal Growth Factor Receptor 1 (HER1) and HER1/2 Inhibitors in Cancer Patients

(2010) B. Nardone et al.   CLINICAL CANCER RESEARCH

Preliminary evidence for a role of mast cells in epidermal growth factor receptor inhibitor–induced pruritus

(2010) Peter Arne Gerber et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The cytokine interleukin-33 mediates anaphylactic shock

(2009) P. N. Pushparaj et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Skin toxicity caused by EGFR antagonists-An autoinflammatory condition triggered by deregulated IL-1 signaling?

(2008) Ulrich Rodeck   JOURNAL OF CELLULAR PHYSIOLOGY